An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Zhejiang University
University of Nebraska
Instituto do Cancer do Estado de São Paulo
Massachusetts General Hospital
Western Sydney Local Health District
Augusta University
Oslo University Hospital
Ziekenhuis Oost-Limburg
University of Chicago